VT
VRTX icon

Vise Technologies’s Vertex Pharmaceuticals VRTX Stock Holding History

Vise Technologies’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.91M Buy
7,882
+2,623
+50% +$1.16M 0.04% 335
2026
Q1 		$2.38M Hold
5,259
– – 0.05% 320
2025
Q4 		$2.38M Buy
5,259
+1,036
+25% +$447K 0.05% 321
2025
Q3 		$1.65M Sell
4,223
-55
-1% -$23K 0.06% 299
2025
Q2 		$1.9M Buy
+4,278
New +$1.97M 0.08% 269
2024
Q4 		$1.13M Buy
2,809
+1,646
+142% +$763K 0.09% 219
2024
Q3 		$541K Buy
+1,163
New +$559K 0.07% 274

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vise Technologies's VRTX Position: Q2 2026 in Review

Vise Technologies increased its Vertex Pharmaceuticals (VRTX) stake by 50% in Q2 2026, buying an estimated $1.16M and bringing the position to 7,882 shares worth $3.91M. The position accounts for 0.04% of the portfolio, ranked #335.

Vise Technologies first reported a position in VRTX in Q3 2024 and has held it in 7 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Vise Technologies held 7,882 shares of Vertex Pharmaceuticals worth $3.91M as of Q2 2026.
  • Vise Technologies bought 2,623 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.16M.
  • Vertex Pharmaceuticals made up 0.04% of Vise Technologies's portfolio in Q2 2026, its #335 holding.
  • Vise Technologies first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.